Return on R&D Investment (ROI) is a critical metric that gauges the effectiveness of research and development expenditures in driving innovation and financial health.
It directly influences business outcomes such as product development success, market competitiveness, and long-term profitability.
By calculating this KPI, organizations can track results and make data-driven decisions that align with strategic goals.
High ROI indicates successful innovation efforts, while low ROI may signal inefficiencies or misaligned investments.
Executives can leverage this metric to improve operational efficiency and ensure resources are allocated effectively for maximum impact.
High ROI values suggest that R&D investments are yielding substantial returns, indicating effective resource allocation and innovation strategies. Conversely, low values may reflect ineffective projects or misaligned objectives, necessitating a reassessment of R&D priorities. Ideal targets typically exceed industry benchmarks, which can vary by sector.
We have 6 relevant benchmarks in our benchmarks database.
Source: Subscribers only
Source Excerpt: Subscribers only
Formula: Subscribers only
Additional Comments: Subscribers only
| Value | Unit | Type | Company Size | Time Period | Population | Industry | Geography | Sample Size |
| Subscribers only | percent of net sales | industry average | 2019 | R&D-performing/funding businesses | computer/electronic; prof sci/tech services; chemicals; info | United States |
Source: Subscribers only
Source Excerpt: Subscribers only
Formula: Subscribers only
Additional Comments: Subscribers only
| Value | Unit | Type | Company Size | Time Period | Population | Industry | Geography | Sample Size |
| Subscribers only | percent of revenue | industry range | 2024-2025 | companies by industry | pharma; software/ICT; automotive; consumer goods; retail | global |
Source: Subscribers only
Source Excerpt: Subscribers only
Additional Comments: Subscribers only
| Value | Unit | Type | Company Size | Time Period | Population | Industry | Geography | Sample Size |
| Subscribers only | ratio (x) | cohort average by size | large, mid, small pharma | latest year of series | pharmaceutical companies | pharmaceutical | global |
Source: Subscribers only
Source Excerpt: Subscribers only
Formula: Subscribers only
Additional Comments: Subscribers only
| Value | Unit | Type | Company Size | Time Period | Population | Industry | Geography | Sample Size |
| Subscribers only | percent of net sales | average by company size | 250-24,999 and 25,000+ employees | 2022 | R&D-performing/funding businesses | all industries (business) | United States | 45,500 sampled (1,104,000 population) |
Source: Subscribers only
Source Excerpt: Subscribers only
Formula: Subscribers only
Additional Comments: Subscribers only
| Value | Unit | Type | Company Size | Time Period | Population | Industry | Geography | Sample Size |
| Subscribers only | percent of revenue | industry average | top corporate R&D spenders | 2023 | top 2,500 corporate R&D spenders | pharmaceutical; software/ICT services | global | approx 1,700 of top 2,500 |
Source: Subscribers only
Source Excerpt: Subscribers only
Additional Comments: Subscribers only
| Value | Unit | Type | Company Size | Time Period | Population | Industry | Geography | Sample Size |
| Subscribers only | percent (rate of return) | average (meta-analysis) | literature since 2014 | firms (production function studies) | all industries | OECD countries |
Many organizations misinterpret ROI as a straightforward financial metric, overlooking qualitative factors that drive innovation.
Enhancing R&D ROI requires a strategic focus on aligning investments with business outcomes and optimizing processes throughout the innovation lifecycle.
A leading biotech firm faced challenges in demonstrating the value of its R&D investments. Over a 3-year period, its ROI on new drug development stagnated at 12%, raising concerns among stakeholders. To address this, the company launched an initiative called “Innovation Acceleration,” aimed at refining its R&D processes and aligning them with market needs.
The initiative involved implementing agile project management methodologies, allowing teams to pivot quickly based on real-time data and market feedback. Additionally, the firm invested in advanced analytics tools to better track project performance and forecast potential returns. By fostering collaboration between R&D and marketing teams, the firm ensured that new products were developed with customer needs in mind.
Within 18 months, the company saw its ROI increase to 28%, significantly improving stakeholder confidence. The faster time-to-market for new drugs not only enhanced revenue but also positioned the firm as a leader in innovation within its sector. The success of “Innovation Acceleration” transformed the perception of R&D from a cost center to a vital driver of business growth.
This KPI is associated with the following categories and industries in our KPI database:
KPI Depot takes you from KPI intelligence to finished deliverable. Consultants, strategy teams, FP&A leaders, and analytics teams use it to answer the two hardest questions in performance management, what to measure and what the target should be, and then to produce the scorecard itself.
The difference is intelligence, not just data. Anyone can list metrics. Every KPI in KPI Depot carries 13 practical attributes, from formula and measurement approach to diagnostic questions, risk warnings, and Balanced Scorecard perspective, across 15 corporate functions and 153 industries. And every target you set is grounded in our database of 34,304 source-attributed benchmarks, each detailing metric value, company size, time period, industry, geography, sample size, and source. Benchmark data at this scale is otherwise the domain of research services costing thousands to hundreds of thousands of dollars per year.
When your metrics are selected, KPI Depot finishes the job: export an interactive Strategy Map, a Balanced Scorecard with formulas and tracking columns, or a CSV KPI pack, and go from research to working deliverable in hours instead of weeks.
Formerly the Flevy KPI Library, KPI Depot is trusted by teams at organizations including Accenture, EY, IBM, PepsiCo, Samsung, and Vodafone.
Got a question? Email us at [email protected].
A good ROI for R&D investments typically exceeds 20%, depending on the industry. High-performing sectors like technology may see even higher benchmarks, reflecting the rapid pace of innovation.
Companies can improve their R&D ROI by aligning projects with strategic objectives and utilizing data analytics for performance tracking. Regularly reviewing project outcomes and adjusting strategies based on insights can enhance overall effectiveness.
No, R&D ROI varies significantly across industries due to differing innovation cycles and market dynamics. For example, pharmaceuticals often have longer development timelines compared to tech firms, impacting ROI calculations.
R&D ROI should be assessed regularly, ideally on a quarterly basis. Frequent evaluations allow organizations to adapt strategies quickly and ensure alignment with evolving market conditions.
Market feedback is crucial for R&D ROI as it informs project adjustments and prioritization. Incorporating customer insights can lead to more successful product launches and higher returns on investment.
Yes, R&D ROI directly influences funding decisions. Higher ROI can attract more investment, while low ROI may lead to reduced funding and increased scrutiny of R&D initiatives.
Each KPI in our knowledge base includes 13 attributes.
A clear explanation of what the KPI measures
The typical business insights we expect to gain through the tracking of this KPI
An outline of the approach or process followed to measure this KPI
The standard formula organizations use to calculate this KPI
Insights into how the KPI tends to evolve over time and what trends could indicate positive or negative performance shifts
Questions to ask to better understand your current position is for the KPI and how it can improve
Practical, actionable tips for improving the KPI, which might involve operational changes, strategic shifts, or tactical actions
Recommended charts or graphs that best represent the trends and patterns around the KPI for more effective reporting and decision-making
Potential risks or warnings signs that could indicate underlying issues that require immediate attention
Suggested tools, technologies, and software that can help in tracking and analyzing the KPI more effectively
How the KPI can be integrated with other business systems and processes for holistic strategic performance management
Explanation of how changes in the KPI can impact other KPIs and what kind of changes can be expected
NEW Mapping to a Balanced Scorecard perspective (financial, customer, internal process, learning & growth)